Tána Uhlíková

发表

Unusual binding mode of an HIV-1 protease inhibitor explains its potency against multi-drug-resistant virus strains.

Thomas Klimkait, Martin Svec, Jirí Vondrásek, 2002, Journal of molecular biology.

An ethylenamine inhibitor binds tightly to both wild type and mutant HIV-1 proteases. Structure and energy study.

Pavel Majer, Jan Dohnálek, Tereza Skálová, 2003, Journal of medicinal chemistry.